These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34569358)

  • 1. Low plasma hyaluronan is associated with faster functional decline in patients with amyotrophic lateral sclerosis.
    Holdom CJ; Ngo ST; McCombe PA; Henderson RD; Steyn FJ
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 Feb; 23(1-2):42-48. PubMed ID: 34569358
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials.
    van Eijk RPA; Eijkemans MJC; Ferguson TA; Nikolakopoulos S; Veldink JH; van den Berg LH
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):156-161. PubMed ID: 29084868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of amyotrophic lateral sclerosis with cognitive and behavioural changes based on a sixty-month longitudinal follow-up.
    Ye S; Jin P; Chen L; Zhang N; Fan D
    PLoS One; 2021; 16(8):e0253279. PubMed ID: 34379621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of postprandial ghrelin, liver-expressed antimicrobial peptide 2 and leptin levels with body composition, disease progression and survival in patients with amyotrophic lateral sclerosis.
    Howe SL; Holdom CJ; McCombe PA; Henderson RD; Zigman JM; Ngo ST; Steyn FJ
    Eur J Neurol; 2024 Jan; 31(1):e16052. PubMed ID: 37658515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
    Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M; Shaw G
    J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):467-72. PubMed ID: 23117489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary neopterin: A novel biomarker of disease progression in amyotrophic lateral sclerosis.
    Shepheard SR; Karnaros V; Benyamin B; Schultz DW; Dubowsky M; Wuu J; Chataway T; Malaspina A; Benatar M; Rogers ML
    Eur J Neurol; 2022 Apr; 29(4):990-999. PubMed ID: 34967083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural MRI outcomes and predictors of disease progression in amyotrophic lateral sclerosis.
    Spinelli EG; Riva N; Rancoita PMV; Schito P; Doretti A; Poletti B; Di Serio C; Silani V; Filippi M; Agosta F
    Neuroimage Clin; 2020; 27():102315. PubMed ID: 32593977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemical correlates of functional decline in amyotrophic lateral sclerosis.
    Cheong I; Deelchand DK; Eberly LE; Marjańska M; Manousakis G; Guliani G; Walk D; Öz G
    J Neurol Neurosurg Psychiatry; 2019 Mar; 90(3):294-301. PubMed ID: 30467209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trials.
    Witzel S; Frauhammer F; Steinacker P; Devos D; Pradat PF; Meininger V; Halbgebauer S; Oeckl P; Schuster J; Anders S; Dorst J; Otto M; Ludolph AC
    Transl Neurodegener; 2021 Aug; 10(1):31. PubMed ID: 34433481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosis.
    Thouvenot E; Demattei C; Lehmann S; Maceski-Maleska A; Hirtz C; Juntas-Morales R; Pageot N; Esselin F; Alphandéry S; Vincent T; Camu W
    Eur J Neurol; 2020 Feb; 27(2):251-257. PubMed ID: 31437330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fat mass loss correlates with faster disease progression in amyotrophic lateral sclerosis patients: Exploring the utility of dual-energy x-ray absorptiometry in a prospective study.
    Lee I; Kazamel M; McPherson T; McAdam J; Bamman M; Amara A; Smith DL; King PH
    PLoS One; 2021; 16(5):e0251087. PubMed ID: 33956876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural imaging differences and longitudinal changes in primary lateral sclerosis and amyotrophic lateral sclerosis.
    Kwan JY; Meoded A; Danielian LE; Wu T; Floeter MK
    Neuroimage Clin; 2012; 2():151-60. PubMed ID: 24179768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological follow-up in amyotrophic lateral sclerosis: decrease in creatinine levels and increase in ferritin levels predict poor prognosis.
    Patin F; Corcia P; Madji Hounoum B; Veyrat-Durebex C; Respaud E; Piver E; Benz-de Bretagne I; Vourc'h P; Andres CR; Blasco H
    Eur J Neurol; 2015 Oct; 22(10):1385-90. PubMed ID: 26095828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of Peripheral Immunity With Rapid Amyotrophic Lateral Sclerosis Progression.
    Murdock BJ; Zhou T; Kashlan SR; Little RJ; Goutman SA; Feldman EL
    JAMA Neurol; 2017 Dec; 74(12):1446-1454. PubMed ID: 28973548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
    Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of spirometric tests in Amyotrophic Lateral Sclerosis patients.
    Pirola A; De Mattia E; Lizio A; Sannicolò G; Carraro E; Rao F; Sansone V; Lunetta C
    Clin Neurol Neurosurg; 2019 Sep; 184():105456. PubMed ID: 31382080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Milano-Torino Staging and Long-Term Survival in Chinese Patients with Amyotrophic Lateral Sclerosis.
    He R; Zheng M; Lian L; Yao X
    Cells; 2021 May; 10(5):. PubMed ID: 34067647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma creatinine and amyotrophic lateral sclerosis prognosis: a systematic review and meta-analysis.
    Lanznaster D; Bejan-Angoulvant T; Patin F; Andres CR; Vourc'h P; Corcia P; Blasco H
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 May; 20(3-4):199-206. PubMed ID: 30961401
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum C-Reactive Protein as a Prognostic Biomarker in Amyotrophic Lateral Sclerosis.
    Lunetta C; Lizio A; Maestri E; Sansone VA; Mora G; Miller RG; Appel SH; Chiò A
    JAMA Neurol; 2017 Jun; 74(6):660-667. PubMed ID: 28384752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermetabolism in ALS is associated with greater functional decline and shorter survival.
    Steyn FJ; Ioannides ZA; van Eijk RPA; Heggie S; Thorpe KA; Ceslis A; Heshmat S; Henders AK; Wray NR; van den Berg LH; Henderson RD; McCombe PA; Ngo ST
    J Neurol Neurosurg Psychiatry; 2018 Oct; 89(10):1016-1023. PubMed ID: 29706605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.